These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 14737822)

  • 21. Cognitive-behavioral group therapy versus sertraline for obsessive-compulsive disorder: five-year follow-up.
    Borges CP; Meyer E; Ferrão YA; Souza FP; Sousa MB; Cordioli AV
    Psychother Psychosom; 2011; 80(4):249-50. PubMed ID: 21540627
    [No Abstract]   [Full Text] [Related]  

  • 22. New developments in the treatment of obsessive-compulsive disorder.
    Leonard HL
    J Clin Psychiatry; 1997; 58 Suppl 14():39-45; discussion 46-7. PubMed ID: 9418745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of obsessive-compulsive disorder in children and adolescents.
    Boileau B
    Dialogues Clin Neurosci; 2011; 13(4):401-11. PubMed ID: 22275846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obsessive-Compulsive Disorders.
    Mathews C
    Continuum (Minneap Minn); 2021 Dec; 27(6):1764-1784. PubMed ID: 34881735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
    Dell'Osso B; Nestadt G; Allen A; Hollander E
    J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
    Simpson HB; Gorfinkle KS; Liebowitz MR
    J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research.
    Simpson HB; Petkova E; Cheng J; Huppert J; Foa E; Liebowitz MR
    J Psychiatr Res; 2008 Jul; 42(8):631-8. PubMed ID: 17892885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commonly asked questions in the treatment of obsessive-compulsive disorder.
    Arumugham SS; Reddy YC
    Expert Rev Neurother; 2014 Feb; 14(2):151-63. PubMed ID: 24372473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmenting obsessive-compulsive disorder treatment: from brain to mind.
    Ressler KJ; Rothbaum BO
    JAMA Psychiatry; 2013 Nov; 70(11):1129-31. PubMed ID: 24026506
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuropsychiatry of obsessive-compulsive disorder in children and adolescents.
    March JS; Leonard HL; Swedo SE
    Compr Ther; 1995 Sep; 21(9):507-12. PubMed ID: 8565438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cognitive-behavior therapy for obsessive-compulsive disorder: a systematic review of the last decade].
    Prazeres AM; Souza WF; Fontenelle LF
    Braz J Psychiatry; 2007 Sep; 29(3):262-70. PubMed ID: 17713699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obsessive-compulsive disorder.
    Bokor G; Anderson PD
    J Pharm Pract; 2014 Apr; 27(2):116-30. PubMed ID: 24576790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining Pharmacotherapy with cognitive-behavioral interventions for obsessive-compulsive disorder.
    Cottraux J; Bouvard MA; Milliery M
    Cogn Behav Ther; 2005; 34(3):185-92. PubMed ID: 16201063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.
    Külz AK; Landmann S; Cludius B; Hottenrott B; Rose N; Heidenreich T; Hertenstein E; Voderholzer U; Moritz S
    BMC Psychiatry; 2014 Nov; 14():314. PubMed ID: 25403813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
    Todorov C; Freeston MH; Borgeat F
    Can J Psychiatry; 2000 Apr; 45(3):257-62. PubMed ID: 10779882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric obsessive-compulsive disorder: an update for advanced practice psychiatric nurses.
    Kameg KM; Richardson L; Szpak JL
    J Child Adolesc Psychiatr Nurs; 2015 May; 28(2):84-91. PubMed ID: 25950460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of treatment response in pediatric obsessive-compulsive disorder.
    Ginsburg GS; Kingery JN; Drake KL; Grados MA
    J Am Acad Child Adolesc Psychiatry; 2008 Aug; 47(8):868-78. PubMed ID: 18596553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obsessive-compulsive disorder. Diagnosis and management.
    Ladouceur R; Freeston M; Gagnon F
    Can Fam Physician; 1996 Jun; 42():1169-72, 1175-8. PubMed ID: 8704492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of pediatric obsessive-compulsive disorder: a review.
    Mancuso E; Faro A; Joshi G; Geller DA
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):299-308. PubMed ID: 20807068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.